Rheumatoid Arthritis Assessment - Risk Factors & Treatment for Rheumatoid Arthritis - RealAge
Links shared publicly online about this topic.
- 0total visits
Rheumatoid Arthritis Assessment - Risk Factors & Treatment for Rheumatoid Arthritis - RealAge
View full resource at realage.com
Tags: Pain, Knee Pain, Arthritis, Rheumatoid Arthritis, Doctor
Most Recently Shared on December 5, 2011 at 8:01 pm By:
Knee Pain Know-How: Use this RealAge tool to analyze your knee pain symptoms and point you toward relief. http://t.co/On5kizSI
ACTEMRA (tocilizumab) | Rheumatoid Arthritis Treatment
actemra.com — “Find information about ACTEMRA, an FDA-approved treatment for rheumatoid arthritis. ACTEMRA is a prescription medicine called an interleukin-6 (IL-6) receptor inhibitor. ACTEMRA is used to treat adults with moderately to severely active rheumatoid arthritis (RA) after at least one other medicine called a Tumor Necrosis Factor (TNF) antagonist has been used and did not work well. ACTEMRA is used to treat people with active systemic juvenile idiopathic arthritis (SJIA) 2 years of age and older. So” View full resource at actemra.com
Most Recently Shared on January 20, 2012 at 3:35 pm By:
Changing rheumatoid arthritis medication stop time may help reduce flare-ups
orthosupersite.com — “Timing anti-tumor necrosis factor medications in rheumatoid arthritis patients appropriately so the stop times coincide with the half-life of t...” View full resource at orthosupersite.com
Most Recently Shared on January 9, 2012 at 3:30 pm By:
Dr. Lisa Mandl: Changing #RheumatoidArthritis medication stop time may help reduce flare-ups. @ORTHOSuperSite http://t.co/GPWytht0
Crossing the Language Barrier of Pain Scales: #Rheum Blog Carnival | RA Education | Rheumatoid Arthritis Warrior
rawarrior.com — “If you either live with or study a rheumatological disease, then you know that pain is a ubiquitous symptom and an essential factor in evaluating disease...” View full resource at rawarrior.com
Most Recently Shared on January 9, 2012 at 11:00 am By:
@RAWarrior: Crossing the Language Barrier of Pain Scales: #Rheum Blog Carnival http://t.co/Thpw0cN6 Full http://t.co/M6NGya5g
Serum Cytokine Concentrations in a Patient with Rheumatoid Arthritis on Etanercept Therapy Who Subsequently Developed Pneumocystis Pneumonia: A Case Report
hindawi.com — “We report a rheumatoid arthritis patient who was treated with etanercept. Serum levels of tumor-necrosis-factor- (TNF-) alpha, soluble-tumor-necrosis-factor receptor- (sTNFR-) I and -II, interleukin- (IL-) 6, and IL-1 beta were measured by ELISA before and during the course of therapy. While the serum levels of IL-6 and IL-1 beta dropped rapidly following the initiation of therapy, the concentrations of TNF-alpha and sTNFR-II steadily increased to a plateau. Although significant clinical efficac” View full resource at hindawi.com
Most Recently Shared on December 16, 2011 at 8:47 pm By:
Serum Cytokine Concentrations in a Patient with Rheumatoid Arthritis on Etanercept Therapy Who Subsequently Deve... http://t.co/Oj8HqkPW
A Prospective Study of Lupus and Rheumatoid Arthritis in Relation to Deployment in Support of Iraq and Afghanistan: The Millennium Cohort Study
hindawi.com — “The objective of this study was to prospectively assess the association between deployment in support of the operations in Iraq and Afghanistan and newly reported lupus and rheumatoid arthritis while also considering the effects of demographic, behavioral, and occupational characteristics. A total of 77,047 (2001–2003) and 31,110 (2004–2006) participants completed the baseline Millennium Cohort questionnaire and were resurveyed approximately every 3 years. Longitudinal analyses were used to asse” View full resource at hindawi.com
Most Recently Shared on November 14, 2011 at 12:55 pm By:
A Prospective Study of Lupus and Rheumatoid Arthritis in Relation to Deployment in Support of Iraq and Afghanist... http://t.co/WJbwD6qJ
Medical News: ACR: RA Disease Activity Rises When Biologic Stopped - in Meeting Coverage, ACR from MedPage Today
medpagetoday.com — “CHICAGO -- The clinical benefits of combination therapy using methotrexate plus adalimumab (Humira) in patients with rheumatoid arthritis were weakened once the tumor necrosis factor (TNF) inhibitor w” View full resource at medpagetoday.com
Most Recently Shared on November 11, 2011 at 4:23 pm By:
Arthritis OW OW Health and Active Health Library
ACR: RA Disease Activity Rises When Biologic Stopped (CME/CE): CHICAGO (MedPage Today) -- The clinical benefits ... http://t.co/wjhY2NXb
NRAS - National Rheumatoid Arthritis Society - Have you got The S Factor?
nras.org.uk — “NRAS provides support, information and advocacy for people with Rheumatoid Arthritis and Juvenile Idiopathic Arthritis, their families, friends and carers. We are also a resource for health professionals with an interest in rheumatology and work closely with rheumatology teams across the UK.” View full resource at nras.org.uk
Most Recently Shared on November 10, 2011 at 3:37 pm By:
Dr. Shashank Akerkar Internist, Rheumatologist, Physician, and Doctor
Have you got the S factor: RA awareness campaign by @NRASociety http://t.co/AWRL0kXx #rheum
Medical News: ACR: Skin Lesions Linked to Biologics in RA Patients - in Meeting Coverage, ACR from MedPage Today
medpagetoday.com — “CHICAGO -- Skin lesions appear to be common among rheumatoid arthritis patients who are treated with tumor necrosis factor (TNF) antagonists, researchers said.” View full resource at medpagetoday.com
Most Recently Shared on November 8, 2011 at 2:56 pm By:
ACR: Skin Lesions Linked to Biologics in RA Patients http://t.co/bdq75CsS
Factors Associated With Treatment Response to Etanercept in Juvenile Idiopathic Arthritis - — JAMA
jama.ama-assn.org — “Factors Associated With Treatment Response to Etanercept in Juvenile Idiopathic Arthritis - — JAMA” View full resource at jama.ama-assn.org
Most Recently Shared on November 6, 2011 at 10:51 pm By:
From #ACR2011 JAMA Online Study: medication for treatment of #juvenilearthritis: http://t.co/B3I9CmkD
Research and Markets: Rheumatoid Arthritis Therapeutics - Pipeline Assessment and Market Forecasts to 2018 | Business Wire
businesswire.com — “Research and Markets (http://www.researchandmarkets.com/research/fb1321/rheumatoid_arthrit) has announced the addition of GlobalData's new report &quo” View full resource at businesswire.com
Most Recently Shared on October 10, 2011 at 12:14 pm By:
Research and Markets: Rheumatoid Arthritis Therapeutics - Pipeline Assessment and Market Forecasts to 2018: DUBL... http://t.co/ISSjJ0hI
Rheumatology Article | Increased levels of thymosin beta4 in synovial fluid of patients with rheumatoid arthritis: association of thymosin beta4 with other factors that are involved in inflammation and bone erosion in joints
mdlinx.com — “Increased levels of thymosin beta4 in synovial fluid of patients with rheumatoid arthritis: association of thymosin beta4 with other factors that are involved in inflammation and bone erosion in joints” View full resource at mdlinx.com
Most Recently Shared on September 24, 2011 at 10:20 am By:
Sandeep Pulim MD Physician, Doctor, and Health Communicator
Increased levels of thymosin beta4 in synovial fluid of patients with rheumatoid arthritis: associ... http://t.co/8CSLB35j #Rheumatology
Rheumatology Article | Arthritis, Rheumatoid
mdlinx.com — “Efficacy of leflunomide addition in relation to prognostic factors for patients with active early rheumatoid arthritis failing to methotrexate in daily practice” View full resource at mdlinx.com
Most Recently Shared on September 17, 2011 at 11:09 am By:
Sandeep Pulim MD Physician, Doctor, and Health Communicator
Efficacy of leflunomide addition in relation to prognostic factors for patients with active early ... http://t.co/M2iTzcSS #Rheumatology
Rheumatology Article | Arthritis, Rheumatoid
mdlinx.com — “Delayed treatment with tumor necrosis factor inhibitors in incomplete responders to synthetic disease-modifying anti-rheumatic drugs shows an excellent effect in patients with very early rheumatoid arthritis with poor prognosis factors” View full resource at mdlinx.com
Most Recently Shared on September 14, 2011 at 9:57 pm By:
Sandeep Pulim MD Physician, Doctor, and Health Communicator
Delayed treatment with tumor necrosis factor inhibitors in incomplete responders to synthetic dise... http://t.co/ELPQc0k4 #Rheumatology
Infectious Disease Article | Arthritis, Rheumatoid
mdlinx.com — “Pulmonary tuberculosis and tuberculous arthritis of knee joint associated with rheumatoid arthritis treated with anti-tumor necrosis factor (TNF)-alpha medication: a case report” View full resource at mdlinx.com
Most Recently Shared on September 8, 2011 at 1:16 am By:
Sandeep Pulim MD Physician, Doctor, and Health Communicator
Pulmonary tuberculosis and tuberculous arthritis of knee joint associated with rheumatoid arthritis treated ... http://t.co/V0Ph7pU #ID
Family Medicine Article | Arthritis, Rheumatoid
mdlinx.com — “Emerging Issues in Pharmacological Management of Rheumatoid Arthritis: Results of a National Needs Assessment Survey Identifying Practice Variations for the Development of Canadian Rheumatology Association Clinical Practice Recommendations” View full resource at mdlinx.com
Most Recently Shared on September 2, 2011 at 8:41 pm By:
Sandeep Pulim MD Physician, Doctor, and Health Communicator
Emerging Issues in Pharmacological Management of Rheumatoid Arthritis: Results of a National Needs ... http://t.co/5roum9O #FamPractice
Advertisement
